Company: SYRA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0001493152-25-009873
Chunk: 273

Company: Syra Health Corp
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1A
Chunk 273
---
    in the market valuations of companies similar to ours;

    ●
    announcements
    of significant acquisitions, strategic collaborations, joint ventures or capital commitments by us or our competitors;

    ●
    additions
    or departures of key scientific or management personnel;

    ●
    sales
    of our Class A common stock by us or our stockholders in the future;

    ●
    trading
    volume of our Class A common stock;

    ●
    general
    economic, industry and market conditions;

    ●
    health
    epidemics and outbreaks, such as the COVID-19 pandemic, or other natural or manmade disasters which could significantly disrupt our
    operations; and

    ●
    the
    other factors described in this “Risk Factors” section.

Any
of these factors may result in large and sudden changes in the volume and price at which our Class A common stock will trade. In addition,
the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices
of equity securities of many companies. If there is extreme market volatility and trading patterns in our Class A common stock, it may
create several risks for investors, including the following:

    ●
    the
    market price of our Class A common stock may experience rapid and substantial increases or decreases unrelated to our actual or expected
    operating performance, financial condition or prospects, which may make it more difficult for prospective investors to assess the
    rapidly changing value of our Class A common stock;

    ●
    if
    our future market capitalization reflects trading dynamics unrelated to our actual or expected operating performance, financial performance
    or prospects, purchasers of our Class A common stock could incur substantial losses as prices decline once the level of market volatility
    has abated; and

    ●
    if
    the future market price of Class A our common stock declines, investors may be unable to resell their shares at or above the price
    at which they acquired them. We cannot assure you that the market of our Class A common stock will not fluctuate or decline significantly
    in the future, in which case you could incur substantial losses.

Broad
market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may negatively affect the
market price of our Class A common stock, regardless of our actual operating performance. In addition, shares of our Class A common stock
may be more thinly traded than securities of larger, more established healthcare